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The cause of rheumatoid arthritis (RA) as a chronic inflammatory autoimmune 
disease is still unknown. It appears that both genetic and environmental factors 
play a role in its pathogenesis. Recent studies reveal that in addition to the CNS, 
immune cells synthesis neurotransmitters so that these catecholamines can 
regulate immune functions. The aim of this study is to evaluate the dopamine 
receptor gene expression profiles on peripheral blood mononuclear cells of 
rheumatoid arthritis patients in comparison with normal individuals.
Material & Methods
In the present study, we investigated dopamine receptor gene expression in 
PBMCs of 40 RA patients and 40 healthy individuals using Real Time-PCR.The 
specificities of the obtained Real time PCR products for the respective dopamine 
receptors fragments were confirmed by sequenced analysis capillary system 
Results
We found that DRD1-DRD5 types of dopamine receptors genes expression 
profiles of rheumatoid arthritis patients differ compared to healthy individuals. 
Moreover, a significant difference of DR2 and DR4 gene expression was seen 
in rheumatoid arthritis patients.
Conclusion
This study showed that some types of dopamine receptors genes expression 
profiles alter in rheumatoid arthritis patients with comparison to healthy 
individuals Moreover, this alteration possibly could result in dysfunction of 
dopaminergic system in immune cells and finally lead to rheumatoid arthritis.
Keywords: Rheumatoid arthritis, Dopamine receptor, Gene expression, Human 
peripheral blood lymphocytes, Real Time- Polymerase Chain Reaction
Introduction
Rheumatoid arthritis is traditionally considered a chronic, inflammatory, 
multisystem, autoimmune disorder that causes the immune system to attack the 
joints. It is a disabling and painful inflammatory condition, which can lead to 
substantial loss of mobility due to pain and joint destruction. RA which affects 
about 1% of the population in worldwide is two to three times more frequent in 
women than men and can lead to disability and reduced quality of life (1). The 
cause of RA is still unknown, but both genetic and environmental factors appear 
to play a role (2). It is suspected that susceptibility to rheumatoid arthritis is an 
inherited trait. The association with certain human leukocyte antigen (HLA) and 
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RA has been recognized for a long time (3), and it is 
found that rather specific amino acid sequences, the so-
called shared epitope (SE) confer the highest risk for 
developing RA (4). Recently in a study of blood bank 
donors it was demonstrated that approximately half of 
patients with RA had specific serologic abnormalities 
(rheumatoid factor and anti-CCP antibodies) several 
years before the onset of symptoms (5). The earliest 
events in RA might involve activation of the innate 
immune system, which triggers a T-cell response 
possibly directed towards citrullinated proteins (6). 
Recent studies reveal that in addition to CNS, immune 
cells can also synthesis catecholamines and that 
catecholamines can regulate immune functions.
 Human peripheral blood lymphocytes (HPBL) express 
dopamine receptors and dopamine transporters and 
synthesize indigenous dopamine through tyrosine 
hydroxylase dependent pathway. Five different 
dopamine receptor genes (DRD1, DRD2, DRD3, DRD4, 
and DRD5) have been recognized and cloned. Whereas 
DR1-like family receptors (DR1 and DR5) are excitatory, 
DR2-like family (DR2-DR3, DR4) are inhibitory (7). 
Changes in the dopamine system are influenced not only 
by dopamine itself, but also by dopamine receptors that 
are encoded by five different dopamine receptor genes 
(DR1-DR5). Althought the expression of the dopamine 
receptors is well characterized in the brain but little work 
has been done to examine their expression in other organ 
tissues. Despite the fact that in certain diseases of the 
nervous systems alterations in dopamine receptors gene 
expression in different cells have been reported (8,9), 
but there is not any evidence that reports investigation 
on dopamine receptors gene expression in peripheral 
blood lymphocytes in RA patient. The aim of the present 
study was to investigate dopamine receptor expression 
in peripheral blood lymphocytes of RA patients against 
the background of the hypothesis, that a persisting 
dysfunction of the dopaminergic system contributes a 
biological cause to the chronic character of autoimmune 
system diseases such as RA. 
Material & Methods
Patients with established RA attending outpatient clinics 
at the Rheumatology Department, Taleghani Hospital, 
Tehran, Iran, were enrolled in this study between 2006 
and 2008. All participants gave informed consent. All 
data used for this study were documented at inclusion. 
Eighty individuals (aged 25-55 years) including forty 
normal individuals and forty patients (31 males, 9 
females) took part in this study. For the controls, age and 
sex matched healthy persons considered. All patients 
fulfilled the ACR criteria and any patients with a previous 
history of neurologic, neuropsychologic, or autoimmune 
disease excluded. All subjects were Iranian peoples that 
had minimum disease duration of 1 year, and also at least 
one definite radiographic erosion on their hands or feet 
(10).
Peripheral blood samples (6ml) were obtained from 
the cubital vein and collected in cell preparation tubes 
containing an anticoagulant (0.05 M EDTA). Peripheral 
blood mononuclear cells (PBMC) were isolated from 
3ml of each blood sample by Ficoll-Hypaque density 
centrifugation (Lymphoprep ™, Oslo, Norway) which its 
density was 1.077 ± 0.001 g/ml (20˚C) and its osmolity 
290 ± 15 mOsm.Horizontal swing out centrifuge was 
used for cells isolation with 2500 rpm, at 20 min and 
1. speed regulation. The buffy coat was collected and 
washed three times in Phosphate buffer saline (PBS).
The total mRNA was isolated from PBMC by High pure 
RNA isolation Kit (Roche, Germany), according to the 
manufacturer’s instructions and the amount and purity of 
RNA were determined by spectrophotometery (11).For 
synthesis of cDNA, 11 μg of total RNA extracted from 
lymphocytes was reverse transcribed into first-strand 
cDNA by using M-MuLV RT (recombinant moloney 
murine leukemia virus reverse transcriptase) according 
to the manufacturers protocols (Revert Aid ™ First 
Strand cDNA Synthesis Kit Fermentas, EU). Samples 
were reverse transcribed with oligodT primers (12). 
The cDNA can be stored up to one week at -20ºC. For 
quantitative analysis of extracted RNA were examined 
by electrophoresis on agarose gel and optical density was 
quantitated by using densitometric scanning imaging 
system. For identity confirmation of synthesized cDNA, 
common PCR reactions were run for 26 cycles using the 
following conditions: at 94 °C for10 second (s), at 58 °C 
for 10 s, at 72 °C for 30 s, and at 72 °C for 5 min. The 
PCR products were visualized by gel electrophoresis 
on a 2% agarose gel to confide concentration of cDNA 
for each sample. Reactions also were carried out in a 
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Real Time-PCR (Roach, Germany) with a Cyber green 
fluorogenic nucleotide to monitor cDNA amplification 
by the increase in Fluorescence intensity and with 
using primer pairs specific for five dopamine receptors 
(DRD1-DRD5) mRNAs and β-actin as internal control 
(All reagents Prepared from Fermentas, EU) (Table1). 
The reaction condition of Real Time-PCR for each of 
D1-D5 receptor and β-actin genes was different. The 
specificities of the obtained Real Time-PCR products 
for the respective dopamine receptors fragments were 
confirmed by capillary sequenced analysis (ABI3700, 
Applied Bio system, USA) (13). 
Statistical analysis
We used SPSS 16.0 (SPSS, Inc, Chicago, IL) and test to 
analysis the data of RA patients in comparison of healthy 
individuals. Relative mRNA expression calculated with 
the δδCt-method (14).The significant value in this study 
was less than 0.05 (P≤ 0.05). 
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Table1.Primer sequences of Dopamine Receptors & β-actin





 DRD1 5’AAACCCACAAGCCCCTCTGA 3’ 5’GATGAATTAGCCCACCCAAAC 3’ 471 bp NM_000794.3
DRD2 5’GCGGACAGACCCCACTACAA 3’ 5’AAGGGCACGTAGAAGGAGA 3’ 521 bp NM_000795.2
DRD3 5’CCGCATTTGCTGTGATGTT 3’ 5’TTTGGGTTGCCTTCTTCT 3’ 670 bp NM_000796.3
DRD4 5’CCTGCGGCTCCAACTGTGC 3’ 5’GGAAGCCCCGACCACCAC 3’ 153 bp NM_000797.2
DRD5 5’AACCTGTGCGTCATCAGCG 3’ 5’CAGATCCATGAGGGGGTTT 3’ 1078 bp NM_000798.3
β Actin 5’TGAAGTGTCACGTGGACATCCG 3’ 5’GCTGTCACCTTCACCGTTCCAG 3’ 447 bp NM_001101.2
Results
We examined detection of the mRNA expressions of 
dopamine receptors in PBMC with highly sensitive 
methods. We focused on the all subtypes of dopamine 
receptors (DRD1-DRD5). Expression of the different 
dopamine receptors genes segments was studied by 
analyzing mRNA extracted from the samples. In order 
to detect dopamine gene receptors expression on RNA 
level, Real time PCR was performed for the regions of 
different dopamine receptors. At the end, the Real Time-
PCR products were sequenced by capillary sequenced 
analysis. Therefore, results revealed that all dopamine 
receptors genes subtypes were expressed on PBMC of 
patients and healthy individuals. The size of dopamine 
receptors gene-specific amplicon was different on gel 
electrophoresis. They consist from left to right: lane 1; 
Molecular Weight Marker dopamine receptor, Lane 2; 
DRD1 (size 471 bp), Lane 3; DRD2 (size 521 bp), Lane 
4; DRD3 (size 670 bp), Lane5; DRD4 (size 153), and 
Fig 1: Agarose gel electrophoresis of PCR product of dopamine receptors genes
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Lane6; DRD5 (size 1078) (Figure 1).
Concentration of samples was calculated. In addition, 
Mean, Standard deviation and P Value for D1-D5 were 
determined (Table2).
Table 2. Comparison of the expression pattern of human 








D1 9.1137±14.4261 4.8777±7.0967 0.194
D2 2199.4605±3130.8097 207.4748±820.6691 0.011
D3 109443.28 ±158934.836 1149816.31±1149816.31 0.118
D4 1.0563 ±2.6446 5.2109 ±11.1688 0.014
D5 23129.712 ±27109.3537 20277.913 ±27576.9155 0.674
*All value of dopamine receptor genes concentration is relative to 
beta actin concentration
However, when RA patients and matched normal 
individuals were analyzed for D1, D2, D3, D4 and 
D5 receptors genes expression by Real time PCR 
and normalized to the housekeeping gene β-actin for 
each sample with the δδCt method, for RA patients, 
considering P≤ 0.05, we determined a lower expression 
of D2 receptor compared to the normal individuals 
group (P value = 0.011, Mean ± SD + 2199.4605±313
0.8097 for normal and 207.4748  ± 820.6691 for RA 
patients) (Figure 2); however our analysis showed that 
PBMC from RA patients express significantly higher 
amounts of D4 receptor mRNA compared to normal 
individuals (significant P= 0.014, 1.0563 ± 2.6446 for 
normal and 5.2109 ± 11.1688 for RA patients) (Figure3). 
No significant differences were found for D1, D3 and 
D5 mRNA expression between the healthy and patient 
groups.
Fig 2: The D2 dopamine receptor gene expression
 reduced in RA patients. 
 
Fig 3: The D4 dopamine receptor gene expression
  increased in RA patients
Discussion
The bidirectional interactions between the 
neuroendocrine and immune systems are mediated 
by anatomical connections and mediators released and 
recognized by both systems, implying neuroendocrine 
hormones and neuropeptides produced by immune cells 
and cytokines by neuroendocrine cells; common receptors 
expressed on cells of the immune and neuroendocrine 
systems; effects of neuroendocrine mediators on immune 
functions; and effects of cytokines on the neuroendocrine 
system. Autoimmune diseases in general are complex 
genetic diseases where genes and environment interact 
in unknown ways (15). Rheumatoid arthritis (RA) is 
one of the common autoimmune disorders usually 
considered as a chronic, inflammatory; multisystem 
that causes the immune system to attack the joints.The 
cause of rheumatoid arthritis is a very active area of 
worldwide research (16). Neurotransmitters are signal 
substances that have traditionally been regarded as 
mediators of signal states between cells in the nervous 
system. Whereas the mechanisms of neurotransmitter 
regulation in CNS are well understood, only recently 
new evidence come to light elucidating the modulatory 
role of neurotransmitters in immune function (17). In 
certain diseases of the immune and nervous systems, 
alterations in dopamine receptors gene expression in 
different cells have been reported (18).
Individual vulnerability to develop autoimmune disease 
is associated with both genetic and environmental factors. 
Association studies in such patients have explored the 
contribution of gene variants in the dopaminergic system 
in these disorders. This system is involved in motor 
control, endocrinological function, the reward system 
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and cognition. The diverse physiological functions of 
dopamine are mediated by five different dopamine 
receptors. Dopamine receptors belong to a large super-
gene family of receptors which are linked to their signal 
transduction pathways through heterotrimeric G proteins 
(19). A variety of signaling events are known to be regulated 
by dopamine receptors including adenylate cyclase and 
phospholipase activities and various ion channels (20). 
Disturbances in dapaminergic transmission may cause 
some disorders, and the receptors are primary targets 
for drugs used to treat the disorders. The human genome 
is known to contain five genes encoding the functional 
dopamine receptors, DRDl, DRD2, DRD3, DRD4 and 
DRD5, and two genes highly homologous to the DRDS 
encoding the seudogenes. Receptors are belonging to 
two subfamilies; D1 like and D2 like subfamilies. The 
D1 subfamily consists of two receptors-the D1 and D5, 
whereas the D2, D3 and D4 receptors comprise the D2 
subfamily (21).
Dopamine and its receptor might play a role in the 
regulation of the immune system. In one study, reverse 
transcriptase-polymerase chain reaction (RT-PCR) 
was used to investigate the expression of mRNA for 
the different subtypes of dopamine receptors in the 
lymphocytes in the way that D1, D2, D3, D4 and D5 
receptor mRNAs were identified. These results provide 
further evidence for the interaction of dopamine systems 
and the immune system, and suggest further investigation 
regarding the immunosuppressive actions of dopamine 
and dopaminergic drugs might depend on a direct 
interaction with dopamine receptors on the lymphocyte 
membrane (22).In previous studies the expression of 
dopamine receptors on human immune cells has been 
investigated by using dopaminergic legends, RT-PCR or 
flow cytometry (23). 
It has been repeatedly suggested that dopamine receptor 
expression in peripheral blood lymphocytes reflects, to 
some extent, brain status (24). The PBMC could assume 
as one of subsets of dopaminergic model in neuroimmune 
system. The aim of the present study was to investigate 
dopamine receptor expression in peripheral blood 
lymphocytes of RA patients against the background 
of the hypothesis, that a persisting dysfunction of the 
dopaminergic system contributes a biological cause to 
the chronic character of autoimmune system diseases 
such as RA. Also we suggest further investigation 
on basis of protein detection on separated leukocyte 
subpopulation which will support this hypothesis 
more. It is now largely established that the immune and 
neuroendocrine systems have cross-talk by using their 
ligands and receptors. Since there is evidence regarding 
the possible immunological role of these receptors in 
leukocytes function (25). These results reveal that the 
molecular dopamine receptors on peripheral lymphocytes 
are reactive, and that altered expression of dopamine 
receptor in peripheral lymphocyte of rheumatoid arthritis 
can contribute to clinically significant diagnosis and 
treatment of rheumatoid arthritis 
In conclusion, our results also demonstrate that dopamine 
receptors genes are expressed by PBL, particularly in 
RA, where it localizes on mononuclear cells. The present 
study showed that peripheral leukocytes in human RA 
patient group express dopamine receptors including: 
DRD1, DRD2, DRD3, DRD4 and DRD5 with significant 
difference in comparison with normal individuals. Our 
study indicates that although there are no significant 
differences in the measures of D1, D3 and D5 receptor 
gene expression of two groups (P> 0.05); there are 
significant differences in D2and D4 receptor genes 
between the patient and the control groups (P <0.01).
These observed differences may be helpful and can be 
used for primary diagnosis and treatment of RA.
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